Tuesday, 17 November 2026LatestVideosAboutContact
Latest
New findings reveal how rice blight spreads within plants and where it may stallNewly identified Quebec wasp attacks leafhoppers that spread crop diseasesBRS MLC Dasoju Sravan seeks ACB probe into alleged commission cultureBSFI releases centenary book celebrating 100 years of Indian cue sportsWhat is iQOO 15's 4th-gen silicon anode battery technology and how does it promise longer gaming and streaming hours?SEI opens 1,200-seat GCC in HyderabadIndia vs Pakistan: Is there extra-time and penalty shootout if SAFF Championship final ends in draw?Rajgopal Reddy reminds Congress government of Rs 4,000 Cheyutha pension promiseJacob Bethell to undergo second knee surgery and miss England's South Africa tourIndia’s horticulture production up 4.4% to record 386.92 million tonnes in 2025-26HYDRAA Commissioner, Tahsildar appear before Telangana HCAFG vs ZIM, 2nd Test: Zimbabwe secures thrilling 57-run win over Afghanistan, clinches series 1-0
BusinessUpdated 22 min ago

No FOMO, Sanofi India looks to strengthen presence in rare disease, diabetes and haemophilia segments, says MD

Image: BusinessLine

Over the last 70 years, he said, about 200 trials have been done at 400-odd sites, and presently 18 are underway in future products in segments

Continue reading on BusinessLine

Hello Headlines links you to the original publisher for the full story.

Read full story

More in Business

See all